Osimertinib Impurity 13 | CAS 2364486-23-5 - Request Quote
Osimertinib Impurity 13
| SZ CAT No: | SZ-O014036 |
| CAS No | 2364486-23-5 |
| Mol.F. | C13H10ClN3 |
| Mol.Wt. | 243.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Osimertinib Impurity 13 is chemically 3-(4-Chloropyrimidin-2-yl)-1-methyl-1H-indole. Osimertinib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Osimertinib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Osimertinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2364486-23-5
Purchase 2364486-23-5
Order 2364486-23-5
Enquire 2364486-23-5
price of 2364486-23-5
2364486-23-5 Supplier
2364486-23-5 Manufacturer
2364486-23-5 Exporter
buy high quality Osimertinib Impurity 13
Purchase Osimertinib Impurity 13
Osimertinib Impurity 13 suppliers
Osimertinib Impurity 13 manufacturers
Osimertinib Impurity 13 price
Order Osimertinib Impurity 13
Enquire Osimertinib Impurity 13
Osimertinib Impurity 13 cost
Osimertinib Impurity 13 Supplier
Osimertinib Impurity 13 Distributor
Osimertinib Impurity 13 for Method Validation
Osimertinib Reference Standard
Osimertinib Impurity 13 for ANDA Filing
Osimertinib Impurity 13 for Forced Degradation Studies
Osimertinib Impurity 13 Identification Standards
Osimertinib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


